Report Detail
Global Targeted RNA Sequencing Market Insights, Forecast to 2025
- RnM3234501 |
- 02 April, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Other
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Targeted RNA Sequencing market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Targeted RNA Sequencing market based on company, product type, end user and key regions.
This report studies the global market size of Targeted RNA Sequencing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Targeted RNA Sequencing in these regions.
This research report categorizes the global Targeted RNA Sequencing market by top players/brands, region, type and end user. This report also studies the global Targeted RNA Sequencing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Market size by Product
enrichment approaches
amplicon-based approaches
Market size by End User
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Targeted RNA Sequencing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Targeted RNA Sequencing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Targeted RNA Sequencing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Targeted RNA Sequencing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Targeted RNA Sequencing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Targeted RNA Sequencing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Targeted RNA Sequencing Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Targeted RNA Sequencing Market Size Growth Rate by Product
- 1.4.2 enrichment approaches
- 1.4.3 amplicon-based approaches
- 1.5 Market by End User
- 1.5.1 Global Targeted RNA Sequencing Market Size Growth Rate by End User
- 1.5.2 Research Institutes
- 1.5.3 Hospitals & Clinics
- 1.5.4 Biotechnology Company
- 1.5.5 Diagnostic Lab
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Targeted RNA Sequencing Market Size
- 2.1.1 Global Targeted RNA Sequencing Revenue 2014-2025
- 2.1.2 Global Targeted RNA Sequencing Sales 2014-2025
- 2.2 Targeted RNA Sequencing Growth Rate by Regions
- 2.2.1 Global Targeted RNA Sequencing Sales by Regions
- 2.2.2 Global Targeted RNA Sequencing Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Targeted RNA Sequencing Sales by Manufacturers
- 3.1.1 Targeted RNA Sequencing Sales by Manufacturers
- 3.1.2 Targeted RNA Sequencing Sales Market Share by Manufacturers
- 3.1.3 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)
- 3.2 Targeted RNA Sequencing Revenue by Manufacturers
- 3.2.1 Targeted RNA Sequencing Revenue by Manufacturers (2014-2019)
- 3.2.2 Targeted RNA Sequencing Revenue Share by Manufacturers (2014-2019)
- 3.3 Targeted RNA Sequencing Price by Manufacturers
- 3.4 Targeted RNA Sequencing Manufacturing Base Distribution, Product Types
- 3.4.1 Targeted RNA Sequencing Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Targeted RNA Sequencing Product Type
- 3.4.3 Date of International Manufacturers Enter into Targeted RNA Sequencing Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Targeted RNA Sequencing Sales by Product
- 4.2 Global Targeted RNA Sequencing Revenue by Product
- 4.3 Targeted RNA Sequencing Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Targeted RNA Sequencing Breakdown Data by End User
6 North America
- 6.1 North America Targeted RNA Sequencing by Countries
- 6.1.1 North America Targeted RNA Sequencing Sales by Countries
- 6.1.2 North America Targeted RNA Sequencing Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Targeted RNA Sequencing by Product
- 6.3 North America Targeted RNA Sequencing by End User
7 Europe
- 7.1 Europe Targeted RNA Sequencing by Countries
- 7.1.1 Europe Targeted RNA Sequencing Sales by Countries
- 7.1.2 Europe Targeted RNA Sequencing Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Targeted RNA Sequencing by Product
- 7.3 Europe Targeted RNA Sequencing by End User
8 Asia Pacific
- 8.1 Asia Pacific Targeted RNA Sequencing by Countries
- 8.1.1 Asia Pacific Targeted RNA Sequencing Sales by Countries
- 8.1.2 Asia Pacific Targeted RNA Sequencing Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Targeted RNA Sequencing by Product
- 8.3 Asia Pacific Targeted RNA Sequencing by End User
9 Central & South America
- 9.1 Central & South America Targeted RNA Sequencing by Countries
- 9.1.1 Central & South America Targeted RNA Sequencing Sales by Countries
- 9.1.2 Central & South America Targeted RNA Sequencing Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Targeted RNA Sequencing by Product
- 9.3 Central & South America Targeted RNA Sequencing by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Targeted RNA Sequencing by Countries
- 10.1.1 Middle East and Africa Targeted RNA Sequencing Sales by Countries
- 10.1.2 Middle East and Africa Targeted RNA Sequencing Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Targeted RNA Sequencing by Product
- 10.3 Middle East and Africa Targeted RNA Sequencing by End User
11 Company Profiles
- 11.1 Thermo Fisher
- 11.1.1 Thermo Fisher Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Thermo Fisher Targeted RNA Sequencing Products Offered
- 11.1.5 Thermo Fisher Recent Development
- 11.2 Illumina
- 11.2.1 Illumina Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Illumina Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Illumina Targeted RNA Sequencing Products Offered
- 11.2.5 Illumina Recent Development
- 11.3 Roche Holdings
- 11.3.1 Roche Holdings Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Roche Holdings Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Roche Holdings Targeted RNA Sequencing Products Offered
- 11.3.5 Roche Holdings Recent Development
- 11.4 BGI
- 11.4.1 BGI Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BGI Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BGI Targeted RNA Sequencing Products Offered
- 11.4.5 BGI Recent Development
- 11.5 Eurofins
- 11.5.1 Eurofins Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Eurofins Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Eurofins Targeted RNA Sequencing Products Offered
- 11.5.5 Eurofins Recent Development
- 11.6 LabCorp
- 11.6.1 LabCorp Company Details
- 11.6.2 Company Business Overview
- 11.6.3 LabCorp Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 LabCorp Targeted RNA Sequencing Products Offered
- 11.6.5 LabCorp Recent Development
- 11.7 Berry Genomics
- 11.7.1 Berry Genomics Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Berry Genomics Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Berry Genomics Targeted RNA Sequencing Products Offered
- 11.7.5 Berry Genomics Recent Development
- 11.8 Macrogen
- 11.8.1 Macrogen Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Macrogen Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Macrogen Targeted RNA Sequencing Products Offered
- 11.8.5 Macrogen Recent Development
- 11.9 GENEWIZ
- 11.9.1 GENEWIZ Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GENEWIZ Targeted RNA Sequencing Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GENEWIZ Targeted RNA Sequencing Products Offered
- 11.9.5 GENEWIZ Recent Development
12 Future Forecast
- 12.1 Targeted RNA Sequencing Market Forecast by Regions
- 12.1.1 Global Targeted RNA Sequencing Sales Forecast by Regions 2019-2025
- 12.1.2 Global Targeted RNA Sequencing Revenue Forecast by Regions 2019-2025
- 12.2 Targeted RNA Sequencing Market Forecast by Product
- 12.2.1 Global Targeted RNA Sequencing Sales Forecast by Product 2019-2025
- 12.2.2 Global Targeted RNA Sequencing Revenue Forecast by Product 2019-2025
- 12.3 Targeted RNA Sequencing Market Forecast by End User
- 12.4 North America Targeted RNA Sequencing Forecast
- 12.5 Europe Targeted RNA Sequencing Forecast
- 12.6 Asia Pacific Targeted RNA Sequencing Forecast
- 12.7 Central & South America Targeted RNA Sequencing Forecast
- 12.8 Middle East and Africa Targeted RNA Sequencing Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Targeted RNA Sequencing Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Targeted RNA Sequencing. Industry analysis & Market Report on Targeted RNA Sequencing is a syndicated market report, published as Global Targeted RNA Sequencing Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Targeted RNA Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
